Search results
Results from the WOW.Com Content Network
The combination fluticasone furoate/umeclidinium bromide/vilanterol product is approved by the US Food and Drug Administration with an indication for the maintenance treatment of a chronic lung problem called chronic obstructive pulmonary disease (COPD) in adults who (1) have already tried fluticasone furoate/vilanterol (brand name Breo Ellipta) but are still experiencing symptoms of airway ...
Trelegy Ellipta (fluticasone furoate, umeclidinium, and vilanterol inhalation powder) Treximet (sumatriptan and naproxen sodium) Trimovate (clobetasone butyrate) Ultiva (remifentanil hydrochloride) Valtrex (valaciclovir hydrochloride) Ventolin (salbutamol sulfate) Ventolin Expectorant (salbutamol sulfate/guaifenesin) Ventolin HFA (albuterol)
The patient advocate [1] may be an individual or an organization, concerned with healthcare standards or with one specific group of disorders. The terms patient advocate and patient advocacy can refer both to individual advocates providing services that organizations also provide, and to organizations whose functions extend to individual patients.
The Ministry of Health is organized into three administrative directorates, with departments and associated agencies as shown below: [3]. Directorate General for Administration and Finance - administration, personnel, budget and finance
The Forest Stewardship Program (FSP) provides assistance to non-industrial private forest owners by encouraging and enabling them for long-term forest management. The program provides landowners with information on development and multi-source planning in an effort to manage private forests for goods and services.